Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficits.

导出 LinkOut

翻译打印收藏纠错

第一作者： Seema,Bansal

第一单位： Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

作者： Seema,Bansal ^[1] ; Madhunika,Agrawal ^[2] ; Saniya,Mahendiratta ^[1] ; Subodh,Kumar ^[1] ; Shiyana,Arora ^[2] ; Rupa,Joshi ^[1] ; Manisha,Prajapat ^[1] ; Phulen,Sarma ^[1] ; Ajay,Prakash ^[1] ; Kanwaljit,Chopra ^[2] ; Bikash,Medhi ^[1]

作者单位： Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. ^[1] Department of Pharmacology, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India. ^[2]

关键词 insulin signaling pathway mTOR inhibitor neurobehavioral deficits

主题词动物(Animals);脑(Brain);胰岛素(Insulin);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);大鼠(Rats);大鼠, Wistar(Rats, Wistar)

DOI 10.1111/fcp.12677

PMID 33783880

发布时间 2022-01-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交